Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
Indian In Vitro Diagnostics Market Analysis 2018
US$ 700.00
... . “Indian In Vitro Diagnostics Market Analysis 2018” research report by KuicK Research is an intriguing text that gives detailed facts and analysis on latest developments in the Indian In Vitro Diagnostics Market landscape. Report gives comprehensive insight on following issues related to development of In Vitro Diagnostics Market in India: Market Overview Market Segment Analysis by Device & Reagents Emerging Market Trends Market Future ...
November 2013
68 pages
Global Cancer Monoclonal Antibodies Pipeline Analysis
US$ 1,500.00
... Pharma gives comprehensive insight on the various Monoclonal Antibodies being developed for the treatment of Cancer. Research report covers all the ... profile in development phase are covered in “Global Cancer Monoclonal Antibodies Pipeline Analysis” research report: Drug Profile Overview Alternate Names for ...
November 2013
660 pages
Indian Diagnostic Market Outlook to 2017
US$ 900.00
... and higher efficiency systems. According to RNCOS’ report, “Indian Diagnostic Market Outlook to 2017”, the diagnostics equipment market, which is divided into In vitro ... been witnessing an increase in the number laboratory tests being outsourced to India. The coming years will see a rise in the share of the ...
October 2013
125 pages
Consensus Outlook: Prostate Cancer- Competition intensifies in race to the top
US$ 7,495.00
... the global prostate cancer market to grow from $3.5 billion in 2012 to $7.7 billion in 2017. Consensus Outlook: Prostate Cancer – Competition intensifies in race to the top analyses the global prostate cancer market players ... data analysis updates over the next 12 months Report Benefits: Consensus Outlook: Prostate Cancer – Competition intensifies in race to the top will allow you to: Evaluate future ...
October 2013
China Diabetes Market Outlook 2018
US$ 1,000.00
... to reach approximately US$ 4.6 Billion by 2018. In RNCOS’ latest report “China Diabetes Market Outlook 2018”, the country’s diabetes market has been segmented ... been extending their product portfolios in order to gain their own market shares. In the end, RNCOS concludes with a competitive analysis of major ...
October 2013
50 pages
Emerging NIPT Market in Asia Pacific
US$ 1,200.00
... study, we have selected the APAC region since it represents a highly underpenetrated market with immense potential for growth. APAC houses almost a third of global population. According to our report, “Emerging NIPT Market in Asia Pacific” there are around 1 Million potential patients in the region ...
October 2013
50 pages
China Food Safety Testing Industry Report, 2013-2015
US$ 2,200.00
... from testing of agricultural and livestock products in the early 1900s. With the issuance of Chinese food safety related laws and regulations as well as the enhancement of food safety supervision, China food safety testing industry has developed rapidly. In 2009-2012, China food ...
October 2013
98 pages
2014 Analysis of the Global Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 26,800.00
... Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of clinical chemistry and immunodiagnostic products by country and individual product ...
October 2013
1115 pages
2014 Analysis of the European Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 15,760.00
... forecasts, supplier shares) $12,800. This comprehensive five-country report contains 900 pages and 335 tables. The report explores future trends in the European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and ...
October 2013
900 pages
2014 Analysis of the Global Transfusion Diagnostics Market: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 26,000.00
... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Commercial/Private Laboratories Military Blood Banks Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...
October 2013
800 pages
2014 Analysis of the European Transfusion Diagnostics Market: France, Germany, Italy, Spain, UK Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 15,760.00
... and potential market entrants identify and evaluate emerging opportunities in the European transfusion diagnostic market during the next five years, and assist ... B19 NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ...
October 2013
600 pages
Therapy Class Overview : Hepatitis C Virus Infection
US$ 1,000.00
... Oral IFN –Free combinations for Treatment of HCV and ROW opportunity Competitive Landscape - IFN-Free drugs HCV Vaccines and their progress Difficult to treat and drugs for HCV-HIV co infection Market ...
October 2013
33 pages
Colorectal Cancer - KOL Insight Module
US$ 7,495.00
The global market for colorectal cancer (CRC) drugs is undergoing a fundamental shift due to wider generic competition in ... clinical opinion This new KOL Insight report Colorectal Cancer - EGFR inhibitors on the verge of growth provides everyone interested in this dynamic cancer sector with a complete ...
September 2013
127 pages
Competitor Analysis: Pim Kinase Inhibitors
US$ 132.00
... and development of small molecule and siRNA/miRNA inhibitors of the Pim Kinases. In addition, the report lists company-specific R&D pipelines of Pim Kinase inhibitors. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of Compound, ...
September 2013
17 pages
2014 Opportunities in the Global Clinical Chemistry and Immunodiagnostics Markets
US$ 26,800.00
Complete report $33,500. DataPack (test volumes, sales forecasts, supplier shares) $21,800. “2014 Opportunities in the Global Clinical Chemistry and Immunodiagnostics Markets” is a new seven-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...
September 2013
1115 pages
2014 Opportunities in the European Clinical Chemistry and Immunodiagnostics Markets
US$ 15,760.00
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. '2014 Opportunities in the European Clinical Chemistry and Immunodiagnostics Markets' is a new five-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...
September 2013
900 pages
2014 Opportunities in the French Clinical Chemistry and Immunodiagnostics Markets
US$ 4,880.00
... 100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the French Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... the next five years. The report explores future trends in the French market; provides estimates of the specimen, test and sales volumes ...
September 2013
542 pages
2014 Opportunities in the German Clinical Chemistry and Immunodiagnostics Markets
US$ 4,880.00
... 100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the German Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... the next five years. The report explores future trends in the German market; provides estimates of the specimen, test and sales volumes ...
September 2013
578 pages
2014 Opportunities in the Italian Clinical Chemistry and Immunodiagnostics Markets
US$ 4,880.00
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the Italian Clinical Chemistry and Immunodiagnostics Markets” is a new strategic analysis of major business opportunities emerging in the Italian clinical chemistry and immunodiagnostic markets ...
September 2013
561 pages
2014 Opportunities in the Japanese Clinical Chemistry and Immunodiagnostics Markets
US$ 6,080.00
... 600. DataPack (test volumes, sales forecasts, supplier shares) $4,900. “2014 Opportunities in the Japanese Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... next five years. The report explores future trends in the Japanese market; provides estimates of the specimen, test and sales volumes ...
September 2013
559 pages
2014 Opportunities in the Spanish Clinical Chemistry and Immunodiagnostics Markets
US$ 4,880.00
... 100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the Spanish Clinical Chemistry and Immunodiagnostics Markets” is a new strategic ... next five years. The report explores future trends in the Spanish market; provides estimates of the specimen, test and sales volumes, ...
September 2013
568 pages
2014 Opportunities in the UK Clinical Chemistry and Immunodiagnostics Markets
US$ 4,880.00
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Opportunities in the UK Clinical Chemistry and Immunodiagnostics Markets” is a new strategic analysis of major business opportunities emerging in the UK clinical chemistry and immunodiagnostic markets during the ...
September 2013
563 pages
2014 Opportunities in the US Clinical Chemistry and Immunodiagnostics Markets
US$ 9,200.00
Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500 “2014 Opportunities in the US Clinical Chemistry and Immunodiagnostics Markets” is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the ...
September 2013
600 pages
Competitor Analysis: Wnt Pathway Inhibitors
US$ 132.00
... antibody inhibitors of the Wnt ligand or its receptors Frizzled and LRP5/6 in oncology. In addition, the report lists company-specific R&D pipelines of Wnt pathway inhibitors. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of ...
September 2013
16 pages